Navigation Links
Mary-Dell Chilton von Syngenta ist Gewinnerin des Welternährungspreises 2013
Date:6/20/2013

WASHINGTON, 21. Juni 2013 /PRNewswire/ -- US-Außenminister John Kerry war heute Vorsitzender einer Zeremonie, in deren Rahmen die Syngenta-Wissenschaftlerin Mary-Dell Chilton, Ph.D., als Gewinnerin des renommierten Welternährungspreises (World Food Prize) 2013 angekündigt wurde. Der Preis ist die wichtigste internationale Auszeichnung für Einzelpersonen, die durch die verbesserte Qualität, Quantität oder Verfügbarkeit von Lebensmitteln in der Welt zur Verbesserung der menschlichen Entwicklung beigetragen haben.

Dr. Chilton und zwei andere Preisträger wurden für „revolutionäre biotechnologische Entdeckungen ausgezeichnet, die den Schlüssel zur Transformation pflanzlicher Zellen geliefert haben". Dr. Chiltons bahnbrechende, molekulare Forschung zeigte, wie ein Pflanzenbakterium als Werkzeug dazu dienen kann, Gene aus einem anderen Organismus in Pflanzenzellen einzupflanzen, die neue innovative Sorten hervorbringen können. Auf der Grundlage dieser Erkenntnisse konnte Ciba-Geigy (heute Syngenta) 1996 als erstes Unternehmen gentechnisch veränderten Mais vermarkten. Bis 2012 wurden transgene Kulturpflanzen auf mehr als 170 Millionen Hektar von über 17 Millionen Landwirten angebaut.

Mike Mack, CEO von Syngenta, erklärte: „Mary-Dell Chilton steht für das Unternehmensziel von Syngenta: bringing plant potential to life, d.h. das Potenzial der Pflanzen voll auszunutzen. Sie ist eine Pionierin der modernen Biotechnologie, die einen wichtigen Bestandteil der integrierten Lösungen darstellt, welche Landwirte benötigen, um den steigenden Anforderungen einer schnell wachsenden Weltbevölkerung hinsichtlich Lebensmitteln, Futtermitteln und Brennstoffen gerecht zu werden." 

'/>"/>
SOURCE Syngenta
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Syngentas Mary-Dell Chilton named 2013 World Food Prize laureate
2. Syngenta Opens Unique $72 Million Advanced Crop Lab
3. Syngenta Holds Annual General Meeting
4. Syngenta and Bayer CropScience Propose a Comprehensive Action Plan to Help Unlock EU Stalemate on Bee Health
5. Bayer CropScience and Syngenta Submit Herbicide-tolerance Soybean Trait for Approval in Various Countries
6. Syngenta Licenses Plant Sensory Systems' Technology
7. Ceres and Syngenta to Collaborate on Sweet Sorghum Market Development
8. Syngenta divests US flowers distribution and brokerage
9. Syngenta Secures EU Approval For Next Generation Fungicide
10. Pasteuria Bioscience to be Acquired by Syngenta
11. Syngenta to acquire Pasteuria Bioscience
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Sanofi, un leader mondial ... pour le premier semestre 2015. Le Directeur Général ... Visionner l,interview vidéo et lire la transcription ... Au sommaire de l,interview :  - ... - Diabète - Praluent ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... , the Company,s Chief Financial Officer has resigned.  The ... Chief Financial Officer who retired in December 2014, as ... for a permanent successor.     Andy Ashworth ... Laurin and ensure a smooth transition.  Andy was the ...
(Date:7/29/2015)... 29, 2015 Research ... addition of the "Global Biosimilars Market, 2015 ... The Global Biosimilars Market, 2015 - 2025, ... growing biosimilars market. With the blockbuster biologics losing ... costs, biosimilars are being viewed as viable substitutes ...
(Date:7/29/2015)... July 29, 2015  Pfenex Inc. (NYSE MKT: PFNX) ... will be released on Thursday, August 13, 2015, before ... Pfenex management will host a conference call to discuss ... press release outlining the financial results and business update ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) and ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2
... Divine Skin (OTC Bulletin Board: DSKX ) has ... its diverse consumer goods business and accelerate development through its ... RECORD 2010 REVENUE.  Divine Skin started the ... $1.9 million or 55 percent over 2009. ...
...  MedTRACK, an Informa business unit, and the world,s ... unveiled a premier partnering tool for the J.P. ... attending the conference find licensing, investment and acquisition ... Filter companies can quickly identify like-minded suitors in ...
... a privately held biotechnology company that develops next ... receive a milestone payment from Boehringer Ingelheim.  The ... agreement executed in October 2010 to discover, develop ... Re-Targeting (DART) platform.  The amount of the milestone ...
Cached Biology Technology:Another Successful Year at Divine Skin 2Another Successful Year at Divine Skin 3MedTRACK Unveils Partnering Tool for J.P. Morgan Healthcare Conference 2MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim 2
(Date:7/27/2015)... , July 27, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced that Huawei has selected ... solution for its stylish smartwatch. Huawei chose the ... reliability, low power and highly responsive human interface ... Huawei designers also required a classic round watch ...
(Date:7/21/2015)... July 21, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... announces that it has filed provisional patent 62/192218 ... This invention highlights next generation ... an account, but also the user using unique ...
(Date:7/9/2015)... JOSE, Calif. , July 9, 2015  Synaptics ... interface solutions, announced today that it will report financial ... on Thursday, July 30, 2015 after the close of ... for analysts and investors at 2:00 p.m. PT (5:00 ...   To participate on the live call, ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2
... Every creature has its place and role in the oceans ... may lead to more accurate models of ocean change. , ... niche for most animals and plants ?a shark, for example, ... have been relegated to an also-ran world of "functional redundancy" ...
... a rare disease in which patients develop multiple, benign skin ... throughout the body, according to a report in the May ... from the loss of a gene called CYLD, causing tumors ... indicated a role for CYLD in inflammation, but the mechanism ...
... When a faulty protein wreaks havoc in cells and ... finger at a wayward gene. Now scientists are learning ... gene is perfectly normal. The diseases can be caused ... not executed properly, leading to a lethal buildup of ...
Cached Biology News:Bacteria can help predict ocean change 2Gene first linked to rare disease may trigger skin cancer, other tumors 2Gene first linked to rare disease may trigger skin cancer, other tumors 3'Sticky' mice lead to discovery of new cause of neurodegenerative disease 2'Sticky' mice lead to discovery of new cause of neurodegenerative disease 3'Sticky' mice lead to discovery of new cause of neurodegenerative disease 4
Request Info...
Agarose-LE, 500 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Request Info...
Request Info...
Biology Products: